CAIRO (Reuters) - The Saudi Food and Drug Authority said on Wednesday it had given its approval to use Pfizer's COVID-19 vaccine for those between five and eleven years of age.
CAIRO (Reuters) – The Saudi Food and Drug Authority said on Wednesday it had given its approval to use Pfizer‘s COVID-19 vaccine for those between five and eleven years of age.
The authority added in a statement its decision was “based on data provided by the company, which showed the vaccine met the special regulatory requirements”.
(Reporting by Ahmed Tolba; Writing by Ahmad Elhamy; Editing by Peter Graff)
Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products:
